INTRODUCTION: Portal vein embolization (PVE) stimulates hypertrophy of the future liver remnant (FLR) and may improve the safety of extended hepatectomy. The efficacy of PVE was evaluated. METHODS: Records of 358 consecutive patients who underwent PVE before intended major hepatectomy at our institution from 1995 through 2012 were retrospectively reviewed. RESULTS: One hundred twelve patients (31.3 %) had right PVE alone; 235 (65.6 %) had right PVE plus segment IV embolization. The first-session PVE completion rate was 97.8 %. The PVE complication rate was 3.9 %. The median pre-PVE and post-PVE standardized FLRs were 19.5 % (interquartile range, 15.0-25.9) and 29.7 % (interquartile range, 22.5-38.2), respectively. Two hundred forty patients (67.0 %) underwent potentially curative resection. Sixty-two patients (25.8 %) had major post-hepatectomy complications; rates of postoperative hepatic insufficiency and 90-day liver-related mortality were 8.3 and 3.8 %, respectively. The proportion of patients with colorectal liver metastasis increased from 38.6 % before 2005 to 78.2 % in 2010-2012. Despite increased use of preoperative chemotherapy, postoperative hepatic insufficiency and 90-day liver-related mortality rates dropped from 10.6 and 4.1 %, respectively, before 2010 to 2.9 and 2.9 %, respectively, in 2010-2012. CONCLUSIONS: PVE can be safely performed with minimal morbidity. Most patients can proceed to extended hepatectomy, which is associated with a minimal mortality rate.
INTRODUCTION: Portal vein embolization (PVE) stimulates hypertrophy of the future liver remnant (FLR) and may improve the safety of extended hepatectomy. The efficacy of PVE was evaluated. METHODS: Records of 358 consecutive patients who underwent PVE before intended major hepatectomy at our institution from 1995 through 2012 were retrospectively reviewed. RESULTS: One hundred twelve patients (31.3 %) had right PVE alone; 235 (65.6 %) had right PVE plus segment IV embolization. The first-session PVE completion rate was 97.8 %. The PVE complication rate was 3.9 %. The median pre-PVE and post-PVE standardized FLRs were 19.5 % (interquartile range, 15.0-25.9) and 29.7 % (interquartile range, 22.5-38.2), respectively. Two hundred forty patients (67.0 %) underwent potentially curative resection. Sixty-two patients (25.8 %) had major post-hepatectomy complications; rates of postoperative hepatic insufficiency and 90-day liver-related mortality were 8.3 and 3.8 %, respectively. The proportion of patients with colorectal liver metastasis increased from 38.6 % before 2005 to 78.2 % in 2010-2012. Despite increased use of preoperative chemotherapy, postoperative hepatic insufficiency and 90-day liver-related mortality rates dropped from 10.6 and 4.1 %, respectively, before 2010 to 2.9 and 2.9 %, respectively, in 2010-2012. CONCLUSIONS: PVE can be safely performed with minimal morbidity. Most patients can proceed to extended hepatectomy, which is associated with a minimal mortality rate.
Authors: J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi Journal: Surgery Date: 2000-05 Impact factor: 3.982
Authors: N Kokudo; K Tada; M Seki; H Ohta; K Azekura; M Ueno; K Ohta; T Yamaguchi; T Matsubara; T Takahashi; T Nakajima; T Muto; T Ikari; A Yanagisawa; Y Kato Journal: Hepatology Date: 2001-08 Impact factor: 17.425
Authors: S Hayashi; Y Baba; K Ueno; M Nakajo; F Kubo; S Ueno; T Aikou; T Komokata; N Nakamura; R Sakata Journal: Acta Radiol Date: 2007-09 Impact factor: 1.990
Authors: Yoji Kishi; Eddie K Abdalla; Yun Shin Chun; Daria Zorzi; David C Madoff; Michael J Wallace; Steven A Curley; Jean-Nicolas Vauthey Journal: Ann Surg Date: 2009-10 Impact factor: 12.969
Authors: Giuseppe Zimmitti; Robert E Roses; Andreas Andreou; Junichi Shindoh; Steven A Curley; Thomas A Aloia; Jean-Nicolas Vauthey Journal: J Gastrointest Surg Date: 2012-09-07 Impact factor: 3.452
Authors: Sven A Lang; Martin Loss; Volker Benseler; Gabriel Glockzin; Hans J Schlitt Journal: Langenbecks Arch Surg Date: 2015-02-18 Impact factor: 3.445
Authors: Universe Leung; Amber L Simpson; Raphael L C Araujo; Mithat Gönen; Conor McAuliffe; Michael I Miga; E Patricia Parada; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; Yuman Fong; William R Jarnagin Journal: J Am Coll Surg Date: 2014-06-25 Impact factor: 6.113
Authors: Kristoffer W Brudvik; Yoshihiro Mise; Claudius Conrad; Giuseppe Zimmitti; Thomas A Aloia; Jean-Nicolas Vauthey Journal: J Am Coll Surg Date: 2015-02-28 Impact factor: 6.113
Authors: Suguru Yamashita; Eugene Jon Koay; Guillaume Passot; Rachna Shroff; Kanwal P Raghav; Claudius Conrad; Yun Shin Chun; Thomas A Aloia; Randa Tao; Ahmed Kaseb; Milind Javle; Christopher H Crane; Jean-Nicolas Vauthey Journal: Cancer Date: 2016-12-16 Impact factor: 6.860
Authors: Nhatrang Le; Douglas C Rivard; Rebecca M Rentea; Michelle Manalang; Walter Andrews; Bartholomew Kane; Richard J Hendrickson Journal: Pediatr Surg Int Date: 2018-03-29 Impact factor: 1.827